/Join_Us.gif)
Gene Logic Collaborates with FDA
Gene Logic Inc. has announced that it has entered into a collaboration with the United States Food and Drug Administration (FDA) to share quality control methods and metrics that may be useful in better understanding disparate genomic data sent as part of regulatory submissions.
The collaboration is part of the FDA's Critical Path Initiative, an effort to stimulate and facilitate the use of new scientific and technical methods-such as computer-based predictive models and biomarkers for safety and effectiveness-intended to improve the predictability and efficiency of drug development from laboratory concept to commercially approved medicines.
Gene Logic is well known in the pharmaceutical and biotechnology industry as a pioneer and quality leader in obtaining and analyzing genomic data, having assembled one of the world's largest and most detailed knowledge bases of gene expression profiles from human tissues and cells.
For further information visit the Gene Logic homepage.
